Folgen
Meredith M. Regan, ScD
Meredith M. Regan, ScD
Dana-Farber Cancer Institute, Harvard Medical School
Bestätigte E-Mail-Adresse bei ds.dfci.harvard.edu
Titel
Zitiert von
Zitiert von
Jahr
Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor–targeted agents: results from a large …
DYC Heng, W Xie, MM Regan, MA Warren, AR Golshayan, C Sahi, ...
Journal of clinical oncology 27 (34), 5794-5799, 2009
22432009
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group
M Dowsett, TO Nielsen, R A’Hern, J Bartlett, RC Coombes, J Cuzick, ...
Journal of the National cancer Institute 103 (22), 1656-1664, 2011
20132011
Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk
HK Meier-Ewert, PM Ridker, N Rifai, MM Regan, NJ Price, DF Dinges, ...
Journal of the American College of Cardiology 43 (4), 678-683, 2004
14042004
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial
V Galimberti, BF Cole, S Zurrida, G Viale, A Luini, P Veronesi, P Baratella, ...
The lancet oncology 14 (4), 297-305, 2013
12702013
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
G Curigliano, HJ Burstein, EP Winer, M Gnant, P Dubsky, S Loibl, ...
Annals of Oncology 28 (8), 1700-1712, 2017
12242017
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer
Q Wang, W Li, Y Zhang, X Yuan, K Xu, J Yu, Z Chen, R Beroukhim, ...
Cell 138 (2), 245-256, 2009
10672009
External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study
DYC Heng, W Xie, MM Regan, LC Harshman, GA Bjarnason, ...
The lancet oncology 14 (2), 141-148, 2013
10142013
Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma
DF McDermott, MM Regan, JI Clark, LE Flaherty, GR Weiss, TF Logan, ...
Journal of clinical oncology 23 (1), 133-141, 2004
10102004
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
B Asselain, W Barlow, J Bartlett, J Bergh, E Bergsten-Nordström, J Bliss, ...
The Lancet Oncology 19 (1), 27-39, 2018
8872018
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer
O Pagani, MM Regan, BA Walley, GF Fleming, M Colleoni, I Láng, ...
New England Journal of Medicine 371 (2), 107-118, 2014
8662014
Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update.
KH Allison, MEH Hammond, M Dowsett, SE McKernin, LA Carey, ...
8432020
Adjuvant ovarian suppression in premenopausal breast cancer
PA Francis, MM Regan, GF Fleming, I Láng, E Ciruelos, M Bellet, ...
New England Journal of Medicine 372 (5), 436-446, 2015
8422015
The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer
MM Pomerantz, N Ahmadiyeh, L Jia, P Herman, MP Verzi, ...
Nature genetics 41 (8), 882-884, 2009
7812009
Tailoring adjuvant endocrine therapy for premenopausal breast cancer
PA Francis, O Pagani, GF Fleming, BA Walley, M Colleoni, I Láng, ...
New England Journal of Medicine 379 (2), 122-137, 2018
6112018
Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019
HJ Burstein, G Curigliano, S Loibl, P Dubsky, M Gnant, P Poortmans, ...
Annals of Oncology 30 (10), 1541-1557, 2019
5912019
Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy …
G Viale, MM Regan, E Maiorano, MG Mastropasqua, P Dell'Orto, ...
Journal of Clinical Oncology 25 (25), 3846-3852, 2007
5312007
Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer
M Atkins, M Regan, D McDermott, J Mier, E Stanbridge, A Youmans, ...
Clinical cancer research 11 (10), 3714-3721, 2005
5172005
Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline
LA Korde, MR Somerfield, LA Carey, JR Crews, N Denduluri, ES Hwang, ...
Journal of Clinical Oncology 39 (13), 1485, 2021
5022021
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
HJ Burstein, G Curigliano, B Thürlimann, WP Weber, P Poortmans, ...
Annals of oncology 32 (10), 1216-1235, 2021
4682021
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical …
MM Regan, P Neven, A Giobbie-Hurder, A Goldhirsch, B Ejlertsen, ...
The lancet oncology 12 (12), 1101-1108, 2011
4622011
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20